Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
54 hedge funds and large institutions have $339M invested in Myovant Sciences Ltd. in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 3 closing their positions.
767% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 3
400% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 4
69% more funds holding
Funds holding: 32 → 54 (+22)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less capital invested
Capital invested by funds: $544M → $339M (-$205M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$58.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.3M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$44.8M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$27.5M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$27.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.5M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$922K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$752K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$123K |
MYOV Hedge Fund Activity: Q2 2019 in Review
54 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2019, worth a combined $339M — down 38% from $544M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MYOV positions and 3 closed out — a net gain of 23 holders — while 20 added to existing stakes and 4 trimmed.
The largest buyer was Bellevue Group, opening a new position worth an estimated $58.3M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $15.5M sold.
- 54 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2019, up from 32 in Q1 2019.
- Funds reported $339M of Myovant Sciences Ltd. stock for Q2 2019, down 38% quarter-over-quarter.
- 26 funds opened new Myovant Sciences Ltd. positions in Q2 2019 and 3 closed out, a net change of +23 holders.
- The largest Myovant Sciences Ltd. buyer in Q2 2019 was Bellevue Group, an estimated $58.3M added.
- The largest Myovant Sciences Ltd. seller in Q2 2019 was Cormorant Asset Management, an estimated $15.5M sold.
Based on aggregated 13F filings for Q2 2019.